VANCOUVER, Aug. 29, 2018 /CNW/ - INVICTUS MD STRATEGIES
CORP. ("Invictus" or the "Company") (TSXV: GENE; OTC: IVITF; FRA:
8IS1) is pleased to announce that its wholly-owned Alberta subsidiary, Acreage Pharms Ltd.
("Acreage Pharms"), has signed a Purchase Order
("PO") with Alberta Gaming, Liquor and Cannabis
("AGLC") to supply the province with a selection of premium
cannabis products for the upcoming adult recreational market. The
agreement includes an initial one-year term, with two one-year
renewal options.
Invictus' Acreage Pharms Ltd. ("Acreage Pharms"), fully
licensed under the Access to Cannabis for Medical Purposes
Regulations ("ACMPR"), is scaling up with new
state-of-the-art purpose-built indoor facilities. Phases 1, 2 and 3
are expected to bring Acreage Pharm's gross cultivation space to
130,000 square feet by January 2019,
followed by Phase 4 which will add an additional 90,000 square
feet, for a total production capacity of 220,000 square feet.
To complement Acreage Pharms' portfolio of award-winning
strains, Invictus has partnered with world-leading Authentic Brands
Group ("ABG") in New York
to launch a line of distinct lifestyle inspired cannabis brands
that feature its high-quality products for patients and adult
recreational users. Products will include dried flowers, oils and
concentrates, and consumables as regulations permit. The
Company expects to launch one medical brand and four recreational
brands in the coming weeks.
"On October 17, 2018, retailers
across Alberta and the province's
only legal online store, albertacannabis.org, will have
high-quality, locally grown cannabis products to offer consumers,"
said Dan Kriznic, Chairman and CEO of Invictus. "This agreement is
great news for the province of Alberta. Acreage did not have its sales
license when the initial application was submitted to AGLC and was
therefore excluded from the initial AGLC announcement of approved
licensed producers (LP). The provinces, including Ontario, have the ability to approve supply
agreements on an ad-hoc basis following the initial agreements with
LP's. We continue to press on towards multiple supply agreements
across Canada with our initial
main focus to be our home province of Alberta."
The PO with AGLC is the Company's second provincial supply
agreement to service the adult-use market and falls in-line with
Invictus' ambitious five-pillar distribution strategy that includes
medical, adult-use, international, LP to LP and retail stores. To
date, the Company has entered into supply agreements with
British Columbia and Alberta for recreational product and a Letter
of Intent ("LOI") with Germany for medical product, while awaiting
responses to Expressions of Interest ("EOI") submitted to
additional provinces including Ontario.
For more information, please visit www.invictus-md.com.
On Behalf of the Board,
Dan Kriznic
Chairman and CEO
Jessica Martin
Vice President, Public Relations and Regulatory Affairs
(604) 537-8676
About Invictus
Invictus is a global cannabis company offering a selection of
products under a wide range of lifestyle brands. Our integrated
sales approach is defined by five pillars of distribution including
medical, adult-use, international, Licensed Producer to Licensed
Producer and retail stores.
Invictus has partnered with business leaders to convey our
corporate vision, including KISS music legend and business mogul
Gene Simmons as our Chief Evangelist
Officer, and global branding agency Authentic Brands Group.
Invictus is expanding its cultivation footprint, with two cannabis
production facilities fully licensed under ACMPR in Canada and a third awaiting approval,
featuring 100,000 square feet of available grow space today with
200,000 expected by January 2019 and
1 million by end of 2019. The Company will earmark 50 per cent of
production to the medical and recreational markets, respectively.
To ensure consistency in quality and supply, Invictus maintains all
aspects of the growing process through its subsidiary, Future
Harvest Development Ltd., a high-quality Fertilizer and Nutrients
manufacturer. Invictus drives sustainable long-term shareholder
value through a diversified product portfolio with over 69 Health
Canada approved strains and a multifaceted distribution strategy
including medical, recreational, international and retail. For more
information visit www.invictus-md.com.
Cautionary Note Regarding Forward-Looking Statements: This
release includes certain statements and information that may
constitute forward-looking information within the meaning of
applicable Canadian securities laws or forward-looking statements
within the meaning of the United States Private Securities
Litigation Reform Act of 1995. All statements in this news release,
other than statements of historical facts, including statements
regarding future estimates, plans, objectives, timing, assumptions
or expectations of future performance, including the potential
production capacity of Invictus, are forward-looking statements and
contain forward-looking information. Generally, forward-looking
statements and information can be identified by the use of
forward-looking terminology such as "intends" or "anticipates", or
variations of such words and phrases or statements that certain
actions, events or results "may", "could", "should", "would" or
"occur". Forward-looking statements are based on certain material
assumptions and analysis made by the Company and the opinions and
estimates of management as of the date of this press release,
including that Invictus will be successful in reaching its
potential production capacity, its production facilities will be
completed as anticipated, regulatory approval will be granted as
anticipated, Invictus will reach full production capacity on the
timeline anticipated by the Company, and no unforeseen
construction delays will be experienced. These
forward-looking statements are subject to known and unknown risks,
uncertainties and other factors that may cause the actual results,
level of activity, performance or achievements of the Company to be
materially different from those expressed or implied by such
forward-looking statements or forward-looking information.
Important factors that may cause actual results to vary, include,
without limitation, Invictus will not be successful in
reaching its potential production capacity, its production
facilities will not be completed as anticipated, and licenses
or approvals being granted on terms or timelines that are
materially worse than expected by the Company. Although
management of the Company has attempted to identify important
factors that could cause actual results to differ materially from
those contained in forward-looking statements or forward-looking
information, there may be other factors that cause results not to
be as anticipated, estimated or intended. There can be no assurance
that such statements will prove to be accurate, as actual results
and future events could differ materially from those anticipated in
such statements. Accordingly, readers should not place undue
reliance on forward-looking statements and forward-looking
information. Readers are cautioned that reliance on such
information may not be appropriate for other purposes. The Company
does not undertake to update any forward-looking statement,
forward-looking information or financial out-look that are
incorporated by reference herein, except in accordance with
applicable securities laws.
Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
View original content with
multimedia:http://www.prnewswire.com/news-releases/acreage-pharms-secures-supply-agreement-with-alberta-gaming-liquor--cannabis-commission-300704007.html
SOURCE Invictus MD Strategies